JPS5673025A - Metabolism exciting agent - Google Patents
Metabolism exciting agentInfo
- Publication number
- JPS5673025A JPS5673025A JP15093879A JP15093879A JPS5673025A JP S5673025 A JPS5673025 A JP S5673025A JP 15093879 A JP15093879 A JP 15093879A JP 15093879 A JP15093879 A JP 15093879A JP S5673025 A JPS5673025 A JP S5673025A
- Authority
- JP
- Japan
- Prior art keywords
- metabolism
- soybean saponin
- glucopyranosyl
- prevention
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
Abstract
PURPOSE: To provide an agent for exciting metabolism, suppressing the formation of lipid peroxide, useful for the prevention and remedy of arteriosclerosis, myocardosis, cerebral thrombosis, etc. and prevention of senility, and composed of a soybean saponin component and a vehicle.
CONSTITUTION: An agent composed of a soybean saponin component [e.g. a saponin of formula such as 3-0-[β-D-glucopyranosyl(1→2)-β-D-galactopyranosyl ( 1→2 )-β-D-glucuronopyranoxyl ]-21-0-[ β-D-glucopyranosyl( 1→3 )-α-L-arabinopyranosyl]-soyasapogenol A] and a pharmaceutically acceptable vehicle. The administration of the soybean saponin suppresses the production of lipid peroxide in the heart and liver, etc., and its activity is comparable to that of vitamin E. Furthermore, the soybean saponin is safe, available at a low cost, and water-soluble.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54150938A JPS6016925B2 (en) | 1979-11-20 | 1979-11-20 | Metabolic agents |
DE3040246A DE3040246C2 (en) | 1979-10-29 | 1980-10-24 | Soy Saponins A ↓ 1 ↓ and A? 2? and their use |
US06/487,096 US4524067A (en) | 1979-10-29 | 1983-04-21 | Soybean saponins, and a method of isolating the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54150938A JPS6016925B2 (en) | 1979-11-20 | 1979-11-20 | Metabolic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5673025A true JPS5673025A (en) | 1981-06-17 |
JPS6016925B2 JPS6016925B2 (en) | 1985-04-30 |
Family
ID=15507686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54150938A Expired JPS6016925B2 (en) | 1979-10-29 | 1979-11-20 | Metabolic agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6016925B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5955895A (en) * | 1982-09-27 | 1984-03-31 | Osaka Chem Lab | Soyasaponin |
JPS59106410A (en) * | 1982-12-09 | 1984-06-20 | Osaka Chem Lab | Cosmetic composition containing saponin of soybean |
JPS60224629A (en) * | 1984-04-23 | 1985-11-09 | Kao Corp | Inhibitor composition for in vivo lipoperoxide formation |
JPS617286A (en) * | 1984-06-22 | 1986-01-13 | Kishimoto Sangyo Kk | Production of isolated saponin |
JPS617285A (en) * | 1984-06-22 | 1986-01-13 | Kishimoto Sangyo Kk | Extraction of purified saponin |
JPS6124522A (en) * | 1984-07-13 | 1986-02-03 | Kao Corp | Inhibitor composition for formation of skin peroxylipid |
US5141746A (en) * | 1989-11-10 | 1992-08-25 | Nestec S.A. | Process for obtaining genistin malonate and daidzin malonate |
-
1979
- 1979-11-20 JP JP54150938A patent/JPS6016925B2/en not_active Expired
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5955895A (en) * | 1982-09-27 | 1984-03-31 | Osaka Chem Lab | Soyasaponin |
JPS59106410A (en) * | 1982-12-09 | 1984-06-20 | Osaka Chem Lab | Cosmetic composition containing saponin of soybean |
JPS60224629A (en) * | 1984-04-23 | 1985-11-09 | Kao Corp | Inhibitor composition for in vivo lipoperoxide formation |
JPH053453B2 (en) * | 1984-04-23 | 1993-01-14 | Kao Corp | |
JPS617286A (en) * | 1984-06-22 | 1986-01-13 | Kishimoto Sangyo Kk | Production of isolated saponin |
JPS617285A (en) * | 1984-06-22 | 1986-01-13 | Kishimoto Sangyo Kk | Extraction of purified saponin |
JPS6124522A (en) * | 1984-07-13 | 1986-02-03 | Kao Corp | Inhibitor composition for formation of skin peroxylipid |
JPH053454B2 (en) * | 1984-07-13 | 1993-01-14 | Kao Corp | |
US5141746A (en) * | 1989-11-10 | 1992-08-25 | Nestec S.A. | Process for obtaining genistin malonate and daidzin malonate |
Also Published As
Publication number | Publication date |
---|---|
JPS6016925B2 (en) | 1985-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0165352A3 (en) | Clear micellized solutions of fat soluble essential nutrients | |
EP0136011A3 (en) | A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor | |
JPS61280424A (en) | Blood vessel protector | |
KR970061909A (en) | Ginseng saponin intestinal bacterial metabolites and anti-cancer agents containing the same as active ingredients | |
JPS5673025A (en) | Metabolism exciting agent | |
CA2030962A1 (en) | Improvements relating to the administration of pharmaceutical agents | |
JPS5228947A (en) | Oral remedy for hyperlipemia | |
JPS5716818A (en) | Steroid fatty emulsion | |
Aftergood et al. | Effect of oral contraceptives on plasma lipoproteins, cholesterol and alpha-tocopherol levels in young women | |
JPS5718617A (en) | Antilipemic agent | |
JPS57188520A (en) | Antihyperkalemia | |
WO1991015466A3 (en) | Aminopolycarboxylic acid chelating agents | |
JPS5782319A (en) | Antitumor agent | |
JPS5793913A (en) | Enhancing agent for spermous vital power | |
JPS57163315A (en) | Preventing agent and remedy for thrombosis | |
JPS51144733A (en) | A remedy for hepatic failure | |
JPS55122724A (en) | Antidiabetic agent | |
EP0333678A3 (en) | Use of glycerol ethers in the treatment of allergic diseases | |
JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
JPS57116017A (en) | Antithrombogenetic or anticoagulative agent | |
JPS5484034A (en) | Anti-tumor agent | |
JPS51144732A (en) | A remedy for hepatic failure | |
JPS56125305A (en) | Creamy or milky lotion cosmetic | |
JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
EP0242554A3 (en) | Use of coenzyme a as an antimutagenic agent |